Australia markets closed

Aspen Pharmacare Holdings Limited (APN.JO)

Johannesburg - Johannesburg Delayed price. Currency in ZAc (0.01 ZAR)
Add to watchlist
22,013.00-487.00 (-2.16%)
At close: 05:07PM SAST
Currency in ZAc

Valuation measures4

Market cap (intra-day) 97.79B
Enterprise value 122.31B
Trailing P/E 20.09
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.29
Price/book (mrq)1.14
Enterprise value/revenue 2.86
Enterprise value/EBITDA 15.17

Trading information

Stock price history

Beta (5Y monthly) 0.75
52-week change 317.60%
S&P500 52-week change 323.76%
52-week high 323,729.00
52-week low 316,096.00
50-day moving average 322,644.72
200-day moving average 319,768.45

Share statistics

Avg vol (3-month) 31.12M
Avg vol (10-day) 3761.57k
Shares outstanding 5444.24M
Implied shares outstanding 6454.07M
Float 8278.49M
% held by insiders 119.33%
% held by institutions 163.35%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 43.42
Forward annual dividend yield 41.55%
Trailing annual dividend rate 33.42
Trailing annual dividend yield 30.02%
5-year average dividend yield 41.25
Payout ratio 431.21%
Dividend date 3N/A
Ex-dividend date 420 Sept 2023
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in ZAR.

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 11.40%
Operating margin (ttm)16.56%

Management effectiveness

Return on assets (ttm)4.10%
Return on equity (ttm)6.05%

Income statement

Revenue (ttm)42.7B
Revenue per share (ttm)96.12
Quarterly revenue growth (yoy)10.40%
Gross profit (ttm)N/A
EBITDA 9.88B
Net income avi to common (ttm)4.87B
Diluted EPS (ttm)10.96
Quarterly earnings growth (yoy)-13.50%

Balance sheet

Total cash (mrq)11.6B
Total cash per share (mrq)26.1
Total debt (mrq)36.12B
Total debt/equity (mrq)42.19%
Current ratio (mrq)1.92
Book value per share (mrq)192.66

Cash flow statement

Operating cash flow (ttm)6.27B
Levered free cash flow (ttm)22.38M